- Novo (NOV TH) +3.5%
- Novo Trial Shows Wegovy’s Heart Benefit in Obesity Patients (2)
- Novo Obesity Outcomes Data and Implications: a Prescriber’s View
- Evolution (E3G1 TH) +2.2%
- BT (BTQ TH) +2.1%
- Essity (ESWB TH) +1.9%
- Vodafone (VODI TH) +1.9%
- Nibe (NJB TH) +1.6%
- Diageo (GUI TH) +1.6%
- Diageo PT Cut to 2,600 pence from 3,000 pence at Morgan Stanley
- AstraZeneca (ZEG TH) +1.4%
- AstraZeneca’s Expansive Oncology Pipeline Suggests a Busy 2024
- LVMH (MOH TH) +1.3%
- Talanx (TLX TH) +1.3%
- Talanx 3Q Ebit EU802M
- AB InBev (1NBA TH) -0.7%
- Fresenius SE (FRE TH) -0.8%
- UPM-Kymmene (RPL TH) -1.2%
- Fresenius Medical (FME TH) -1.6%